Bifidobacterium and Topiramate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bifidobacterium (bifidobacteria) and Topiramate (topiramate). Common drug interactions include muscular weakness among females and somnolence among males.

The phase IV clinical study analyzes what interactions people have when they take Bifidobacterium and Topiramate. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Bifidobacterium?

Bifidobacterium has active ingredients of bifidobacteria. eHealthMe is studying from 5,013 Bifidobacterium users. Check the latest studies of Bifidobacterium.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

56 people who take Bifidobacterium and Topiramate together, and have interactions are studied.

Bifidobacterium and Topiramate drug interactions.

What are the common drug interactions of Bifidobacterium and Topiramate, by gender? *:

female:

  1. Muscular weakness (muscle weakness)
  2. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  3. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  4. Myalgia (muscle pain)
  5. Neck pain
  6. Nerve block (the interruption of signals travelling along a nerve)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  9. Procedural pain
  10. Respiratory depression (respiration has a rate below 12 breaths)

male:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  3. Infection
  4. Insomnia (sleeplessness)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
  8. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  9. Sleep disorder
  10. Sleep-related eating disorder (abnormal eating patterns during the night)

What are the common drug interactions of Bifidobacterium and Topiramate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Glossoptosis
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Secretion discharge

10-19:

  1. Angiopathy (generic term for a disease of the blood vessels)
  2. Loss of consciousness
  3. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  4. Sinusitis (inflammation of sinus)

20-29:

  1. Hyperammonaemia
  2. Near drowning (means a person almost died from not being able to breathe under water)
  3. Liver disorder (liver diseases)

30-39:

  1. Arthralgia (joint pain)
  2. Breast cancer
  3. Drug ineffective
  4. Dyspnoea (difficult or laboured respiration)
  5. Injection site pain
  6. Injection site urticaria (rash of round, red welts on the skin at injection site)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Secretion discharge
  9. Surgery
  10. Weight fluctuation

40-49:

  1. Eyelid ptosis (falling of the upper or lower eyelid)
  2. Hallucination, auditory (perceiving sounds without auditory stimulus)
  3. Headache (pain in head)
  4. Lacrimation increased
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Visual impairment
  7. Asthma
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Heart rate irregular

50-59:

  1. Addison's disease (addison's disease, a hormonal disorder disease)
  2. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  3. Cellulitis (infection under the skin)
  4. Dehydration (dryness resulting from the removal of water)
  5. Diarrhoea
  6. Ear infection
  7. Gastric ulcer (stomach ulcer)
  8. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  9. Infection
  10. Influenza like illness

60+:

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  2. Chronic kidney disease
  3. Oedema peripheral (superficial swelling)
  4. Rash
  5. Rash erythematous (redness of the skin)
  6. Rash pruritic (redness with itching)
  7. Renal failure (kidney dysfunction)
  8. Erythema of eyelid (redness of the eyelid)
  9. Eye disorder
  10. Infection

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 17.86%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 14.29%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 10.71%
  4. Asthma: 6 people, 10.71%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 8.93%
  6. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 5 people, 8.93%
  7. Encephalitis (inflammation of the brain): 5 people, 8.93%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 8.93%
  9. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 7.14%
  10. Drowsiness: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Bifidobacterium and Topiramate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bifidobacterium and Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bifidobacterium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bifidobacterium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topiramate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bifidobacteria and topiramate (the active ingredients of Bifidobacterium and Topiramate, respectively), and Bifidobacterium and Topiramate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: